Description
DEOBLIGATE EXCESS FUNDS-ABBOTT BINAX NOW SUPPLIES
Base award description: ABBOTT BINAX NOW COVID TESTING SUPPLIES
Modification chain · 26 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2021-10-19+$2,017,618= $2,017,618
- Mod P000012021-10-19+$96,485= $2,114,103
- Mod P000022022-01-07+$0= $2,114,103
- Mod P000032022-03-21+$0= $2,114,103
- Mod P000042022-08-08-$269,000= $1,845,103
- Mod P000052022-10-19+$458,040= $2,303,143
- Mod P000062023-01-17-$292,530= $2,010,613
- Mod P000072023-01-17-$12= $2,010,601
- Mod P000082023-02-14-$225,131= $1,785,470
- Mod P000092023-02-14+$0= $1,785,470
- Mod P000112023-03-01+$55,187= $1,840,656
- Mod P000102023-03-09+$0= $1,840,656
- Mod P000122023-05-04-$488,454= $1,352,202
- Mod P000132023-06-15+$1,407= $1,353,609
- Mod P000142023-07-27+$0= $1,353,609
- Mod P000152023-09-14+$81,043= $1,434,652
- Mod P000162023-09-20+$16,209= $1,450,861
- Mod P000172023-12-01-$46,353= $1,404,508
- Mod P000182024-02-06-$66,072= $1,338,436
- Mod P000192024-02-07-$120,727= $1,217,709
- Mod P000212024-04-09-$80,407= $1,137,302
- Mod P000222024-04-10-$6,834= $1,130,468
- Mod P000202024-04-11-$29,849= $1,100,619
- Mod P000232024-06-11-$164,889= $935,731
- Mod P000242024-06-28-$70,414= $865,317
- Mod P000252024-06-28-$5,789= $859,528
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2021-10-19 | +$2,017,618 | $2,017,618 | ABBOTT BINAX NOW COVID TESTING SUPPLIES |
| Mod P00001· FUNDING ONLY ACTION | 2021-10-19 | +$96,485 | $2,114,103 | ABBOTT BINAX NOW COVID TESTING SUPPLIES |
| Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2022-01-07 | +$0 | $2,114,103 | ABBOTT BINAX NOW COVID TESTING SUPPLIES |
| Mod P00003· OTHER ADMINISTRATIVE ACTION | 2022-03-21 | +$0 | $2,114,103 | ABBOTT BINAX NOW COVID TESTING SUPPLIES |
| Mod P00004· FUNDING ONLY ACTION | 2022-08-08 | −$269,000 | $1,845,103 | ABBOTT BINAX NOW COVID TESTING SUPPLIES |
| Mod P00005· EXERCISE AN OPTION | 2022-10-19 | +$458,040 | $2,303,143 | ABBOTT BINAX NOW COVID TESTING SUPPLIES |
| Mod P00006· FUNDING ONLY ACTION | 2023-01-17 | −$292,530 | $2,010,613 | ABBOTT BINAX NOW COVID TESTING SUPPLIES |
| Mod P00007· FUNDING ONLY ACTION | 2023-01-17 | −$12 | $2,010,601 | ABBOTT BINAX NOW COVID TESTING SUPPLIES |
| Mod P00008· FUNDING ONLY ACTION | 2023-02-14 | −$225,131 | $1,785,470 | ABBOTT BINAX NOW COVID TESTING SUPPLIES |
| Mod P00009· OTHER ADMINISTRATIVE ACTION | 2023-02-14 | +$0 | $1,785,470 | ABBOTT BINAX NOW COVID TESTING SUPPLIES |
| Mod P00011· FUNDING ONLY ACTION | 2023-03-01 | +$55,187 | $1,840,656 | ABBOTT BINAX NOW COVID TESTING SUPPLIES |
| Mod P00010· OTHER ADMINISTRATIVE ACTION | 2023-03-09 | +$0 | $1,840,656 | ABBOTT BINAX NOW COVID TESTING SUPPLIES |
| Mod P00012· FUNDING ONLY ACTION | 2023-05-04 | −$488,454 | $1,352,202 | DE-OBIGATING EXCESS FUNDS-ABBOTT BINAX NOW COVID TESTING SUPPLIES |
| Mod P00013· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2023-06-15 | +$1,407 | $1,353,609 | ABBOTT BINAX NOW SUPPLIES |
| Mod P00014· OTHER ADMINISTRATIVE ACTION | 2023-07-27 | +$0 | $1,353,609 | ABBOTT BINAX NOW SUPPLIES |
| Mod P00015· FUNDING ONLY ACTION | 2023-09-14 | +$81,043 | $1,434,652 | ABBOTT BINAX NOW SUPPLIES |
| Mod P00016· FUNDING ONLY ACTION | 2023-09-20 | +$16,209 | $1,450,861 | ABBOTT BINAX NOW SUPPLIES |
| Mod P00017· FUNDING ONLY ACTION | 2023-12-01 | −$46,353 | $1,404,508 | DEOBLIGATE EXCESS FUNDS-ABBOTT BINAX NOW SUPPLIES |
| Mod P00018· FUNDING ONLY ACTION | 2024-02-06 | −$66,072 | $1,338,436 | DEOBLIGATE EXCESS FUNDS-ABBOTT BINAX NOW SUPPLIES |
| Mod P00019· FUNDING ONLY ACTION | 2024-02-07 | −$120,727 | $1,217,709 | DEOBLIGATE EXCESS FUNDS-ABBOTT BINAX NOW SUPPLIES |
| Mod P00021· FUNDING ONLY ACTION | 2024-04-09 | −$80,407 | $1,137,302 | DECREASE EXCESS FUNDS (GRAND J)-ABBOTT BINAX NOW SUPPLIES |
| Mod P00022· FUNDING ONLY ACTION | 2024-04-10 | −$6,834 | $1,130,468 | DEOBLIGATE EXCESS FUNDS-ABBOTT BINAX NOW SUPPLIES |
| Mod P00020· FUNDING ONLY ACTION | 2024-04-11 | −$29,849 | $1,100,619 | DEOBLIGATE EXCESS FUNDS-ABBOTT BINAX NOW SUPPLIES |
| Mod P00023· FUNDING ONLY ACTION | 2024-06-11 | −$164,889 | $935,731 | DEOBLIGATE EXCESS FUNDS-ABBOTT BINAX NOW SUPPLIES |
| Mod P00024· FUNDING ONLY ACTION | 2024-06-28 | −$70,414 | $865,317 | DEOBLIGATE EXCESS FUNDS-ABBOTT BINAX NOW SUPPLIES |
| Mod P00025· FUNDING ONLY ACTION | 2024-06-28 | −$5,789 | $859,528 | DEOBLIGATE EXCESS FUNDS-ABBOTT BINAX NOW SUPPLIES |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI P782RNU1NNK3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25026P0699 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $82,304 | FY2026 |
| 36C24426N0511 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $48,635 | FY2026 |
| 36C25526N0126 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $54,108 | FY2026 |
| 36C24126N0170 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $123,000 | FY2026 |
| 36C24226N0185 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $0 | FY2026 |
| 36C24425N0741 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $48,635 | FY2025 |
Other recipients under 6550 from NETWORK CONTRACT OFFICE 19 (36C259) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25926N0457 | BECTON, DICKINSON AND COMPANY | NETWORK CONTRACT OFFICE 19 (36C259) | $147,256 | FY2026 |
| 36C25926N0353 | QIAGEN, LLC | NETWORK CONTRACT OFFICE 19 (36C259) | $88,310 | FY2026 |
| 36C25926N0292 | FISHER SCIENTIFIC COMPANY L.L.C. | NETWORK CONTRACT OFFICE 19 (36C259) | $165,000 | FY2026 |
| 36C25926N0280 | ALBA BIOSCIENCE, INC. | NETWORK CONTRACT OFFICE 19 (36C259) | $64,078 | FY2026 |
| 36C25926N0316 | POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLC | NETWORK CONTRACT OFFICE 19 (36C259) | $50,343 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25922F0041_3600_36F79721D0073_3600 · retrieved 2026-09-26.